readthroughSign in
CompanyRAPPNasdaqBoston, MA

Rapport Therapeutics Inc.

Rapport Therapeutics develops small molecule precision medicines for neurological and psychiatric disorders using its RAP technology platform.

Stories only
SEC EDGARClinicalTrials.govrapportrx.com
DEF 14AAug 24Latest SEC filing, period to Sep 17
Aug 5Latest story

August 2026